1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione
![1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione price.](/CAS/GIF/345931-85-3.gif)
|
- $150 - $2200
- Product name: 1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione
- CAS: 345931-85-3
- MF: C17H17NO4
- MW: 299.32
- EINECS:
- MDL Number:
- Synonyms:1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione;2,5-Pyrrolidinedione, 1-[2-hydroxy-3-(1-naphthalenyloxy)propyl]-
3 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 25mg
- 250mg
- ManufacturerMedical Isotopes, Inc.
- Product number46688
- Product description1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione
- Packaging250mg
- Price$2200
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberH948605
- Product description1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione
- Packaging25mg
- Price$150
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberH948605
- Product description1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione
- Packaging250mg
- Price$1190
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | 46688 | 1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione | 250mg | $2200 | 2021-12-16 | Buy |
| TRC | H948605 | 1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione | 25mg | $150 | 2021-12-16 | Buy |
| TRC | H948605 | 1-[2-Hydroxy-3-(1-naphthalenyloxy)propyl]-2,5-pyrrolidinedione | 250mg | $1190 | 2021-12-16 | Buy |
Properties
Melting point :144-146°C
storage temp. :-20°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :Pale Yellow
storage temp. :-20°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
form :Solid
color :Pale Yellow
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|